Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window

Background: While intravenous thrombolysis (IVT) in ischemic stroke can be safely applied in telestroke networks within 3 h from symptom onset, there is a lack of evidence for safety in the expanded 3- to 4. 5-h time window. We assessed the safety and short-term efficacy of IVT in acute ischemic str...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Erik Simon, Matin Forghani, Andrij Abramyuk, Simon Winzer, Claudia Wojciechowski, Lars-Peder Pallesen, Timo Siepmann, Heinz Reichmann, Volker Puetz, Kristian Barlinn, Jessica Barlinn
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/04612c12d35e462d887a2f91119797d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:04612c12d35e462d887a2f91119797d1
record_format dspace
spelling oai:doaj.org-article:04612c12d35e462d887a2f91119797d12021-12-01T06:35:24ZIntravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window1664-229510.3389/fneur.2021.756062https://doaj.org/article/04612c12d35e462d887a2f91119797d12021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fneur.2021.756062/fullhttps://doaj.org/toc/1664-2295Background: While intravenous thrombolysis (IVT) in ischemic stroke can be safely applied in telestroke networks within 3 h from symptom onset, there is a lack of evidence for safety in the expanded 3- to 4. 5-h time window. We assessed the safety and short-term efficacy of IVT in acute ischemic stroke (AIS) in the expanded time window delivered through a hub-and-spoke telestroke network.Methods: Observational study of patients with AIS who received IVT at the Stroke Eastern Saxony Telemedical Network between 01/2014 and 12/2015. We compared safety data including symptomatic intracerebral hemorrhage (sICH; according to European Cooperative Acute Stroke Study II definition) and any intracerebral hemorrhage (ICH) between patients admitted to telestroke spoke sites and patients directly admitted to a tertiary stroke center representing the hub of the network. We also assessed short-term efficacy data including favorable functional outcome (i.e., modified Rankin Scale ≤ 2) and National Institutes of Health Stroke Scale (NIHSS) at discharge, hospital discharge disposition, and in-hospital mortality.Results: In total, 152 patients with AIS were treated with IVT in the expanded time window [spoke sites, n = 104 (26.9%); hub site, n = 48 (25.9%)]. Patients treated at spoke sites had less frequently a large vessel occlusion [8/104 (7.7) vs. 20/48 (41.7%); p < 0.0001], a determined stroke etiology (p < 0.0001) and had slightly shorter onset-to-treatment times [210 (45) vs. 228 (58) min; p = 0.02] than patients who presented to the hub site. Both cohorts did not display any further differences in demographics, vascular risk factors, median baseline NIHSS scores, or median baseline Alberta stroke program early CT score (p > 0.05). There was no difference in the frequency of sICH (4.9 vs. 6.3%; p = 0.71) or any ICH (8.7 vs. 16.7%; p = 0.15). Neither there was a difference regarding favorable functional outcome (44.1 vs. 39.6%; p = 0.6) nor median NIHSS [3 (5.5) vs. 2.5 (5.75); p = 0.92] at discharge, hospital discharge disposition (p = 0.28), or in-hospital mortality (9.6 vs. 8.3%; p = 1.0). Multivariable modeling did not reveal an association between telestroke and sICH or favorable functional outcome (p > 0.05).Conclusions: Delivery of IVT in the expanded 3- to 4.5-h time window through a telestroke network appears to be safe with equivalent short-term functional outcomes for spoke-and-hub center admissions.Erik SimonMatin ForghaniAndrij AbramyukSimon WinzerClaudia WojciechowskiLars-Peder PallesenTimo SiepmannHeinz ReichmannVolker PuetzKristian BarlinnJessica BarlinnFrontiers Media S.A.articletelemedicinethrombolysisstrokeacute stroke therapystroke networkNeurology. Diseases of the nervous systemRC346-429ENFrontiers in Neurology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic telemedicine
thrombolysis
stroke
acute stroke therapy
stroke network
Neurology. Diseases of the nervous system
RC346-429
spellingShingle telemedicine
thrombolysis
stroke
acute stroke therapy
stroke network
Neurology. Diseases of the nervous system
RC346-429
Erik Simon
Matin Forghani
Andrij Abramyuk
Simon Winzer
Claudia Wojciechowski
Lars-Peder Pallesen
Timo Siepmann
Heinz Reichmann
Volker Puetz
Kristian Barlinn
Jessica Barlinn
Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window
description Background: While intravenous thrombolysis (IVT) in ischemic stroke can be safely applied in telestroke networks within 3 h from symptom onset, there is a lack of evidence for safety in the expanded 3- to 4. 5-h time window. We assessed the safety and short-term efficacy of IVT in acute ischemic stroke (AIS) in the expanded time window delivered through a hub-and-spoke telestroke network.Methods: Observational study of patients with AIS who received IVT at the Stroke Eastern Saxony Telemedical Network between 01/2014 and 12/2015. We compared safety data including symptomatic intracerebral hemorrhage (sICH; according to European Cooperative Acute Stroke Study II definition) and any intracerebral hemorrhage (ICH) between patients admitted to telestroke spoke sites and patients directly admitted to a tertiary stroke center representing the hub of the network. We also assessed short-term efficacy data including favorable functional outcome (i.e., modified Rankin Scale ≤ 2) and National Institutes of Health Stroke Scale (NIHSS) at discharge, hospital discharge disposition, and in-hospital mortality.Results: In total, 152 patients with AIS were treated with IVT in the expanded time window [spoke sites, n = 104 (26.9%); hub site, n = 48 (25.9%)]. Patients treated at spoke sites had less frequently a large vessel occlusion [8/104 (7.7) vs. 20/48 (41.7%); p < 0.0001], a determined stroke etiology (p < 0.0001) and had slightly shorter onset-to-treatment times [210 (45) vs. 228 (58) min; p = 0.02] than patients who presented to the hub site. Both cohorts did not display any further differences in demographics, vascular risk factors, median baseline NIHSS scores, or median baseline Alberta stroke program early CT score (p > 0.05). There was no difference in the frequency of sICH (4.9 vs. 6.3%; p = 0.71) or any ICH (8.7 vs. 16.7%; p = 0.15). Neither there was a difference regarding favorable functional outcome (44.1 vs. 39.6%; p = 0.6) nor median NIHSS [3 (5.5) vs. 2.5 (5.75); p = 0.92] at discharge, hospital discharge disposition (p = 0.28), or in-hospital mortality (9.6 vs. 8.3%; p = 1.0). Multivariable modeling did not reveal an association between telestroke and sICH or favorable functional outcome (p > 0.05).Conclusions: Delivery of IVT in the expanded 3- to 4.5-h time window through a telestroke network appears to be safe with equivalent short-term functional outcomes for spoke-and-hub center admissions.
format article
author Erik Simon
Matin Forghani
Andrij Abramyuk
Simon Winzer
Claudia Wojciechowski
Lars-Peder Pallesen
Timo Siepmann
Heinz Reichmann
Volker Puetz
Kristian Barlinn
Jessica Barlinn
author_facet Erik Simon
Matin Forghani
Andrij Abramyuk
Simon Winzer
Claudia Wojciechowski
Lars-Peder Pallesen
Timo Siepmann
Heinz Reichmann
Volker Puetz
Kristian Barlinn
Jessica Barlinn
author_sort Erik Simon
title Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window
title_short Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window
title_full Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window
title_fullStr Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window
title_full_unstemmed Intravenous Thrombolysis by Telestroke in the 3- to 4.5-h Time Window
title_sort intravenous thrombolysis by telestroke in the 3- to 4.5-h time window
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/04612c12d35e462d887a2f91119797d1
work_keys_str_mv AT eriksimon intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT matinforghani intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT andrijabramyuk intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT simonwinzer intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT claudiawojciechowski intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT larspederpallesen intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT timosiepmann intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT heinzreichmann intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT volkerpuetz intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT kristianbarlinn intravenousthrombolysisbytelestrokeinthe3to45htimewindow
AT jessicabarlinn intravenousthrombolysisbytelestrokeinthe3to45htimewindow
_version_ 1718405454996963328